Table 1.
General characteristics of the participants
| Characteristics | Total (n=452) |
|---|---|
| Age (yr) | 42.58±9.70 |
| Sex (male/female) | 188 (41.6%)/264 (58.4%) |
| Body weight (kg) | 63.31±12.07 |
| Body mass index (kg/m2) | 23.15±3.12 |
| Waist circumference (cm) | 81.90±8.90 |
| Hip circumference (cm) | 92.87±6.99 |
| Waist hip ratio | 0.88±0.05 |
| Lean body mass (kg) | 45.60±9.71 |
| Fat mass (kg) | 17.71±5.45 |
| Body fat percentage (%) | 27.95±6.18 |
| Systolic blood pressure (mmHg) | 118.68±14.21 |
| Diastolic blood pressure (mmHg) | 74.00±9.86 |
| Total cholesterol (mg/dL) | 188.41±33.27 |
| Triglyceride (mg/dL) | 103.96±74.60 |
| HDL cholesterol (mg/dL) | 52.35±10.90 |
| LDL cholesterol (mg/dL) | 156.85±42.17 |
| AST (IU/L) | 22.74±12.18 |
| ALT (IU/L) | 22.77±18.25 |
| Fasting glucose (mg/dL) | 84.95±12.74 |
| Insulin (μIU/mL) | 4.10±2.64 |
| HOMA-IR | 0.90±0.80 |
| Adiponectin (μg/mL) | 5.64±4.06 |
| Leptin (ng/mL) | 2.08±1.71 |
| DPP-4 concentration (ng/mL) | 501.27±125.94 |
| Log DPP-4 concentration (ng/mL) | 2.69±0.11 |
| Fatty liver (n,%) | 111 (24.6) |
Values are normal distribution and are presented as mean±SD or number (%).
HDL, high density lipoprotein; LDL, low density lipoprotein; AST, aspartate transaminase; ALT, alanine transaminase; HOMA-IR, homeostasis model assessment of insulin resistance; DPP-4, dipeptidyl peptidase-4.